Trial NCT04034225

View at ClinicalTrials.gov 
Org. Study IDs: SNS-301-2-2

Last trial update was posted on 2023-03-24

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Squamous Cell Carcinoma of the Head and Neck

Stopping Reasons

Terminated by the sponsor

Limitations And Caveats

The study stopped prematurely for lack of efficacy 25 patients were enrolled. Lab analyzes were not performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID